L 084

Known as: L-084 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2014
01219992014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
1] Dalhoff K. Worldwide guidelines for respiratory tract infections: community-acquired pneumonia. Int J Antimicrob Agents 2001… (More)
Is this relevant?
2006
2006
We discovered an orally active carbapenem, L-084, through pharmacokinetic studies on various prodrug esters of (1R,5S,6S)-6-[(R… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
2006
2006
An orally active carbapenem L-084, which exhibits high bioavailability in humans, has a 1-(1,3-thiazolin-2-yl)azetidin-3-ylthio… (More)
Is this relevant?
2001
2001
L-084 (a prodrug of LJC 11,036 [L-036]) is a new oral carbapenem. Here we compared the in vitro and in vivo antibacterial… (More)
Is this relevant?
2000
2000
We determined the influence of a new quinolone, DU-6859a, and two oral carbapenems, CS-834 and L-084, on the rat and mouse caecal… (More)
  • table II
Is this relevant?
Review
2000
Review
2000
During the last few decades, several carbapenems have been developed. The major characteristic of the newer drugs, such as MK-826… (More)
Is this relevant?
1999
1999
LJC 11,036 is the active metabolite of L-084, a novel oral carbapenem that exhibits potent broad-spectrum activity. Antibacterial… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
1999
Review
1999
In 1998, about 30 new medicinal chemical entities in the field of antibacterials and antifungals were presented during the 38th… (More)
Is this relevant?